Free Trial

Integer (ITGR) Stock Forecast & Price Target

Integer logo
$140.93 +2.15 (+1.55%)
(As of 01:06 PM ET)

Integer - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
7

Based on 8 Wall Street analysts who have issued ratings for Integer in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 1 has given a hold rating, and 7 have given a buy rating for ITGR.

Consensus Price Target

$139.75
-0.84% Downside
According to the 8 analysts' twelve-month price targets for Integer, the average price target is $139.75. The highest price target for ITGR is $147.00, while the lowest price target for ITGR is $130.00. The average price target represents a forecasted downside of -0.84% from the current price of $140.93.
Get the Latest News and Ratings for ITGR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Integer and its competitors.

Sign Up

ITGR Analyst Ratings Over Time

TypeCurrent Forecast
11/28/23 to 11/27/24
1 Month Ago
10/29/23 to 10/28/24
3 Months Ago
8/30/23 to 8/29/24
1 Year Ago
11/28/22 to 11/28/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$139.75$139.75$133.86$93.83
Forecasted Upside-0.84% Downside9.15% Upside4.21% Upside5.12% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ITGR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ITGR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Integer Stock vs. The Competition

TypeIntegerMedical CompaniesS&P 500
Consensus Rating Score
2.88
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside0.70% Upside25,264.18% Upside6.73% Upside
News Sentiment Rating
Positive News

See Recent ITGR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/25/2024Piper Sandler
2 of 5 stars
 Reiterated RatingOverweight ➝ Overweight$125.00 ➝ $140.00+8.59%
10/25/2024Truist Financial
2 of 5 stars
R. Newitter
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$150.00 ➝ $147.00+14.97%
10/21/2024Benchmark
2 of 5 stars
 Boost TargetBuy ➝ Buy$130.00 ➝ $140.00+7.34%
10/15/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$139.00 ➝ $144.00+8.74%
10/1/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$124.00 ➝ $130.00+1.01%
10/1/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$135.00 ➝ $145.00+12.10%
7/16/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$135.00+12.62%
3/14/2024CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$137.00+20.30%
7/28/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight$87.00 ➝ $94.00+0.52%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:38 PM ET.


ITGR Forecast - Frequently Asked Questions

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Integer is $139.75, with a high forecast of $147.00 and a low forecast of $130.00.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There is currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ITGR shares.

According to analysts, Integer's stock has a predicted downside of -0.84% based on their 12-month stock forecasts.

Integer has been rated by research analysts at Bank of America, Benchmark, Citigroup, KeyCorp, Piper Sandler, and Truist Financial in the past 90 days.

Analysts like Integer more than other "medical" companies. The consensus rating score for Integer is 2.88 while the average consensus rating score for "medical" companies is 2.80. Learn more on how ITGR compares to other companies.


This page (NYSE:ITGR) was last updated on 11/27/2024 by MarketBeat.com Staff
From Our Partners